Top Sell
| Security | Buy ▲ | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Novan Inc | 0 | 24 | 0 | 2 | €0.001 | - | - |
| T2 Biosystems Inc. | 0 | 12 | 0 | 0 | €0.16 | - | - |
| Biofrontera AG | 0 | 2 | 0 | 0 | €0.33 | €0.000 | -100.000% |
| ViewRay Inc | 0 | 3 | 0 | 0 | €0.025 | - | - |
| Nymox Pharmaceutical Corp. | 0 | 2 | 0 | 0 | €0.23 | - | - |
| Bellicum Pharmaceuticals Inc. | 0 | 13 | 0 | 0 | €0.064 | - | - |
| Aspira Womens Health Inc. | 0 | 1 | 0 | 0 | €2.92 | - | - |
| Anavex Life Sciences Corp | 0 | 2 | 0 | 0 | €3.53 | - | - |
| Organovo Holdings Inc. | 0 | 5 | 0 | 0 | €0.98 | - | - |
| Eagle Pharmaceuticals Inc | 0 | 1 | 0 | 0 | €3.84 | - | - |
| Enzo Biochem. Inc. | 0 | 1 | 0 | 0 | €0.95 | - | - |
| Medigene AG | 0 | 2 | 0 | 0 | €1.59 | €1.00 | -37.107% |
| Neptune Wellness Solutions Inc | 0 | 13 | 0 | 0 | €0.14 | - | - |
| Synthetic Biologics Inc. | 0 | 1 | 0 | 1 | €0.39 | - | - |
| Protalix Biotherapeutics Inc. | 1 | 1 | 0 | 1 | €1.07 | €2.00 | 86.480% |
| Minerva Neurosciences Inc. | 1 | 5 | 0 | 1 | €2.26 | €7.00 | 209.735% |
| Trevena Inc. | 1 | 14 | 0 | 3 | €0.33 | €8.37 | 2446.849% |
| Accelerate Diagnostics Inc. | 1 | 1 | 0 | 0 | €0.86 | - | - |
| Carbylan Therapeutics Inc | 1 | 1 | 0 | 0 | €9.80 | €22.00 | 124.490% |
| B.R.A.I.N. Biotechnology Research and Information Network AG | 1 | 1 | 0 | 0 | €2.85 | €30.00 | 952.632% |
| Atara Biotherapeutics Inc. | 2 | 3 | 0 | 0 | €0.62 | €3.00 | 380.461% |
| Coherus Bioscien. | 2 | 2 | 0 | 0 | €2.11 | €3.00 | 42.450% |
| Gritstone Oncology Inc | 2 | 2 | 0 | 0 | €0.91 | €6.53 | 614.551% |
| Avinger Inc. | 2 | 7 | 0 | 0 | €0.34 | €4.64 | 1272.633% |
| Tonix Pharmaceuticals Holding Corp. | 2 | 15 | 0 | 1 | €2.82 | €5.03 | 78.387% |